Research Site

Campo Grande 79080-190

1 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Atherothrombosis, Cardiovascular Death, Diabetes Mellitus, Type 2, Gastroesophageal Junction Adenocarcinoma, HER2-positive Gastric Cancer, Myocardial Infarction, Stroke

Studies at this site

• A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer — Recruiting now
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin — Completed